Close Menu

When Roche yesterday announced its $5.7 billion hostile takeover bid for Illumina, reactions on Twitter were varied and swift, ranging from the humorous — like Stuart Glenn's depiction of what a potential acquisition might be like — to the concerned — "If Roche plans to do to DNA sequencing what it did to PCR, then a lot of genomicists are

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.